At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 78 enrolled
Drug / intervention
Interlaminar Decompressionprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
MiDAS I (Mild® Decompression Alternative to Open Surgery): Vertos Mild Patient Evaluation Study
In Brief
A Phase 4 clinical trial evaluating Interlaminar Decompression for Lumbar Spinal Stenosis. Completed, enrolled 78 participants across 13 sites.
Detailed Summary
This is a multi-center, prospective, clinical study to assess the clinical application and outcomes of MILD® Interlaminar Decompression in patients with symptomatic lumbar spinal stenosis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLumbar Spinal Stenosis
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJul 2008
First PostedAug 2009
Primary CompletionApr 2012
TodayJul 2026
First PostedAug 11, 2009
Enrollment StartJul 1, 2008
Primary CompletionApr 1, 2012
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 16.9 years ago
Interventions
Interlaminar Decompressionprocedure
The MILD® devices used in this study are specialized surgical instruments intended to be used to perform percutaneous lumbar decompression.